I like how Gary said after the updated data in Q1, " we'll be taking that data back to the FDA and getting permission from them and approval from them to do the pivotal registrational study. "
Seems pretty confident we'll be moving to the registrational study.
Add to My Watchlist
What is My Watchlist?